Kalamazoo Forward Ventures

CircNova is a biotechnology company that specializes in the development of non-coding RNA therapies aimed at addressing challenging disease targets. By leveraging artificial intelligence, CircNova generates, analyzes, and identifies circular RNA, which offers various mechanisms of action for therapeutic applications. The company's innovative approach focuses on harnessing the potential of circular RNA to create effective treatments for diseases that are traditionally considered undruggable.

Glidance specializes in creating a self-driving mobility aid designed to enhance independent movement for individuals with sight loss. Utilizing cutting-edge advancements in robotics and artificial intelligence, the company’s platform enables users to navigate their surroundings safely and efficiently, even in crowded spaces. This innovative mobility solution empowers those with visual impairments to confidently reach their desired destinations, such as doorways, stairwells, or park benches, thereby improving their overall quality of life. Through its technology, Glidance aims to revolutionize the way people with disabilities experience mobility, providing them with the support needed for greater independence.